- Filed
- May 13, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 12, 2025 | 25.76M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $2.44B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $2.45B |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $102.74M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $154.28M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $2.57B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $2.59B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $3.14B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $3.21B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $40.74M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $62.25M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 25.1M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $1.65M |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $6.86M |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | $3.03M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$1.32 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$1.32 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $21.22M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$44.07M |
| Revenue | Q1 2025 · Mar 31, 2024 | $90.29M |